Literature DB >> 8621666

Molecular genetic analysis of the human Lewis histo-blood group system. II. Secretor gene inactivation by a novel single missense mutation A385T in Japanese nonsecretor individuals.

T Kudo1, H Iwasaki, S Nishihara, N Shinya, T Ando, I Narimatsu, H Narimatsu.   

Abstract

The Lewis histo-blood group system comprises two major antigens, Lewis a and Lewis b. The Lewis b antigen is a product of two fucosyltransferases, the alpha(1,3/1,4)fucosyltransferase (Lewis enzyme; Fuc-TIII) encoded by the Lewis gene and an alpha(1,2)fucosyltransferase which is not required for synthesis of Lewis a antigen. An enzyme responsible for secreting ABH antigens into body secretions (secretor enzyme) is also one of alpha(1,2)fucosyltransferases. A candidate gene encoding secretor enzyme Sec2 gene was recently cloned by Rouquier, S., Lowe, J. B., Kelly, R. J., Fertitta, A. L., Lennon, G. G., and Giorgi, D. ((1995) J. Biol. Chem. 270, 4632-4639) and Kelly, R. J., Rouquier, S., Giorgi, D., Lennon, G. G., and Lowe, J. B. ((1995) J. Biol. Chem. 270, 4640-4649) who demonstrated a G428A nonsense mutation (Trp143 to terminal codon) in Sec2 of nonsecretors. However, the G428A nonsense mutation discovered in the Sec2 gene of nonsecretors in an ethnic group other than Japanese was not found in any of 45 Japanese nonsecretors, whereas one Filipino who had been erroneously registered as a Japanese possessed the G428A mutation heterozygously. In order to explore the Sec2 gene of a Japanese population, we performed a molecular genetic analysis of the Sec2 gene on 226 Japanese individuals, 21 in a family study and 205 in a random sampling study. We discovered two novel mutations in the Sec2 gene, an A385T missense mutation (Ile129 to Phe) that results in inactivation of Sec2-encoded alpha(1,2)fucosyltransferase and a C357T silent mutation which is irrelevant to amino acid substitution, in Japanese nonsecretors. The analysis of Japanese individuals using the polymerase chain reaction-restriction fragment length polymorphism method found three alleles in the Sec2 gene, the first having no mutation, the second having a C357T mutation, and the third having both C357T and A385T mutations, which we designated as Se1, Se2, and sej, respectively. Among 226 Japanese individuals, 40 having a Le(a+b-) phenotype and 5 having a Le(a-b-) nonsecretor phenotype were homozygous for sej/sej, whereas 149 having a Le(a-b+) phenotype and 32 having a Le(a-b-)-secretor phenotype possessed at least one Se1 or Se2. The frequencies of occurrence of Se1, Se2, and sej among 410 alleles examined in a random sample of 205 Japanese individuals were 15, 46, and 39%, respectively, indicating a rather wide distribution of the sej allele in the Japanese population. The results show that the Sec2 gene really encodes the secretor enzyme alpha(1,2)fucosyltransferase and indicate that a ethnic group-specific nonsense or missense point mutation in the Sec2 gene determines nonsecretor status. The phylogenic aspect and biological significance of the Se and Le genes are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621666     DOI: 10.1074/jbc.271.16.9830

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Helicobacter hepaticus Hh0072 gene encodes a novel alpha1-3-fucosyltransferase belonging to CAZy GT11 family.

Authors:  Lei Zhang; Kam Lau; Jiansong Cheng; Hai Yu; Yanhong Li; Go Sugiarto; Shengshu Huang; Li Ding; Vireak Thon; Peng G Wang; Xi Chen
Journal:  Glycobiology       Date:  2010-05-06       Impact factor: 4.313

2.  The aberrant expression of Lewis a antigen in intestinal metaplastic cells of gastric mucosa is caused by augmentation of Lewis enzyme expression.

Authors:  Y Ikehara; S Nishihara; T Kudo; T Hiraga; K Morozumi; T Hattori; H Narimatsu
Journal:  Glycoconj J       Date:  1998-08       Impact factor: 2.916

Review 3.  Factors influencing the gut microbiome in children: from infancy to childhood.

Authors:  Shreyas V Kumbhare; Dhrati V V Patangia; Ravindra H Patil; Yogesh S Shouche; Nitinkumar P Patil
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

4.  Comparison of oligosaccharides derived from salivary mucin of Japanese secretor and non-secretor individuals of blood group type-A.

Authors:  T Ohmori; H Toyoda; T Toida; T Imanari; H Sato
Journal:  Glycoconj J       Date:  2001-08       Impact factor: 2.916

Review 5.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

6.  Human Milk Oligosaccharides Exhibit Antimicrobial and Antibiofilm Properties against Group B Streptococcus.

Authors:  Dorothy L Ackerman; Ryan S Doster; Jörn-Hendrik Weitkamp; David M Aronoff; Jennifer A Gaddy; Steven D Townsend
Journal:  ACS Infect Dis       Date:  2017-06-13       Impact factor: 5.084

7.  Two new FUT2 (fucosyltransferase 2 gene) missense polymorphisms, 739G-->A and 839T-->C, are partly responsible for non-secretor status in a Caucasian population from Northern Portugal.

Authors:  Jacinta Serpa; Nuno Mendes; Celso A Reis; Luis F Santos Silva; Raquel Almeida; Jacques Le Pendu; Leonor David
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

8.  Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding.

Authors:  Haruko Shirato; Satoko Ogawa; Hiromi Ito; Takashi Sato; Akihiko Kameyama; Hisashi Narimatsu; Zheng Xiaofan; Tatsuo Miyamura; Takaji Wakita; Koji Ishii; Naokazu Takeda
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

9.  Identification of lacto-N-Biose I phosphorylase from Vibrio vulnificus CMCP6.

Authors:  Masahiro Nakajima; Motomitsu Kitaoka
Journal:  Appl Environ Microbiol       Date:  2008-08-22       Impact factor: 4.792

10.  Structural basis for the recognition of Lewis antigens by genogroup I norovirus.

Authors:  Tomomi Kubota; Akiko Kumagai; Hiromi Ito; Sanae Furukawa; Yuichi Someya; Naokazu Takeda; Koji Ishii; Takaji Wakita; Hisashi Narimatsu; Haruko Shirato
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.